Target intelligence / Profile preview

Mitochondrial inner membrane proton conductance (MIMPC)

Target
MIMPC
Molecular classification
Transporter, Ion channel, Mitochondrial protein
01

Overview

Mitochondrial inner membrane proton conductance (MIMPC) is a physiological process characterized by the movement of protons from the intermembrane space back into the mitochondrial matrix, bypassing the ATP synthase (Source 1.1.2). This phenomenon, often referred to as mitochondrial proton leak or uncoupling, dissipates the electrochemical gradient (proton-motive force) and releases energy as heat instead of capturing it as ATP (Source 1.2.1). MIMPC is mediated by the intrinsic permeability of the lipid bilayer and specific transport proteins, most notably the uncoupling proteins (UCP1, UCP2, UCP3) and the adenine nucleotide translocator (ANT) (Source 1.1.2, 1.2.1). Pharmacological modulation of this conductance is a significant therapeutic strategy; increasing conductance (uncoupling) can stimulate metabolism to treat obesity, type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD) (Source 1.3.5, 1.4.2). Additionally, mild uncoupling is thought to reduce the production of reactive oxygen species (ROS), providing potential neuroprotective and cardioprotective effects (Source 1.3.4, 1.5.2). However, the therapeutic use of uncouplers is limited by a narrow safety margin, as excessive conductance can lead to life-threatening hyperthermia and cellular energy failure (Source 1.2.1, 1.3.5).

Other names
Mitochondrial proton leakMitochondrial uncouplingProton conductance of the inner mitochondrial membraneBasal proton conductanceInducible proton leak
02

Mechanism of action

Protonophore, Uncoupling protein activation, Mitochondrial uncoupling, Dissipation of proton-motive force

03

Biological functions

ThermogenesisMetabolic regulationRegulation of reactive oxygen speciesEnergy homeostasisATP synthesis regulation
04

Disease associations

ObesityType 2 diabetesNonalcoholic fatty liver diseaseIschemia-reperfusion injuryCancerCardiovascular disease
05

Safety considerations

HyperthermiaNarrow therapeutic indexATP depletionSystemic toxicityCataracts
06

Interacting drugs

2,4-Dinitrophenol (DNP)

7 more in the full profile.

07

Biomarkers

Oxygen consumption rate (OCR)Mitochondrial membrane potential (ΔΨm)Resting metabolic rate (RMR)Body temperatureATP/ADP ratio

Beyond the preview

Go deeper on Mitochondrial inner membrane proton conductance (MIMPC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial inner membrane proton conductance (MIMPC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call